Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 1122 results found. Search for [ Sun Pharma ]

Results 1040 to 1060 of 1122
PTI
New Delhi, August 12, 2011
Coal production of CIL in the quarter ended June 30 wasmarginally up by 1 per cent to 96.30 million tonnes (MT) over 95.15 MT for thesame period last fiscal.


www.businesstoday.in
August 4, 2011
It would be for the fourth time in the last 15 odd months that the sensex would undergo a change. On May 3 last year, Sun Pharma had made way for Cipla, while on May 26, Grasim was replaced by Jindal Steel. On December 6, ACC was replaced by Bajaj Auto.


PTI
New Delhi, August 3, 2011
The state-run company missed its production target for the April-June quarter, achieving an output of just 96.3 million tonnes against a target of 98.6 million tonnes.


PTI
New Delhi, July 21, 2011
The funds will be spent on new mining projects, as well as for building washeries and buying new machinery and equipment, Chairman and Managing Director N C Jha said.


PTI
Mumbai, June 20, 2011
Defying the weak broader market sentiment, shares of Sun Pharmaceutical and Coal India rose by 3 per cent each on the BSE on Monday, after the exchange said it will include these two stocks in the BSE Sensex from August 8, 2011.


PTI
Mumbai, June 18, 2011
Two Anil Ambani group firms, Reliance Communications and Reliance Infrastructure, will move out of Bombay Stock Exchange's blue chip index Sensex in August.


PTI
Mumbai, June 6, 2011
Brokers said buying activity picked up in the second half of the trading as stocks dipped to attractive low levels amid reports that a fall in crude prices would lower the risk of a higher inflation.


PTI
New Delhi, May 30, 2011
The company, which reported consolidated net sales of Rs 5,721 crore for the year ended March 31, said it expects a growth of 28-30 per cent in the current year.


ITGD Bureau
Mumbai, May 30, 2011
Brokers said investors turned cautious on concerns over rising inflation and interest rates, and preferred to book profits in heavy-weight stocks after two-session of gains, reversing an early firm trend.


Tanvi Varma/Money Today
June 24, 2011
Funds that adopt a guarded approach towards investing in equities show lesser volatility and are good bets for the risk-averse.


Rajiv Bhuva
June 9, 2011
FMCG firms are steady market performers, but those that constantly innovate do better.


PTI
New York, April 27, 2011
The transaction is subject to clearance under the Hart-Scott-Rodino Antitrust Improvements Act, approval by the European Commission and regulatory approval in other jurisdictions.


PTI
April 25, 2011
Under the pact, which comes nearly two weeks after the two firms had agreed to form a joint venture, Sun will have the rights to sell two drugs in the Indian market.


PTI
Mumbai, April 11, 2011
Indian pharma major Sun Pharmaceutical Industries on Monday announced a 50:50 strategic joint venture partnership with global drugmaker Merck and Co Inc to develop, manufacture and commercialise new innovative drugs in emerging markets over the next 2-3 years.


PTI
Mumbai, April 11, 2011
Amid news that the company is likely to enter into a marketing tie up with US drug major Merck & Co, Sun Pharma's shares jumped to touch Rs 455.90 on BSE.


Rahul Oberoi/Money Today
April 25, 2011
Pankaj Pandey, Head of Research, ICICIdirect, tells Rahul Oberoi that it is important to stick to companies that give consistent results over 6-7 years.


PTI
New Delhi, January 31, 2011
Net sales of the company stood at Rs 1,601.07 crore for the third quarter ended December 31, while the same was at Rs 1,020.86 crore in the same period last year.


ITGD Bureau
Mumbai, December 27, 2010
India stocks finished slightly lower on Monday, after trading in a tight range during the session. The Sensex finished 44 points lower at 20,028.


PTI
New Delhi, December 18, 2010
The Indian pharma and healthcare sectors repeatedly hit headlines this year on account of M&As, but inbound buyouts by MNCs raised concerns over availability of low-cost drugs.


PTI
New Delhi, November 24, 2010
The company has set the record date for giving the shareholders five equity shares with a nominal face value of Re 1 each, for every equity of Rs 5 face value held by them.


PAGES 53 OF 57  5152535455